February 19, 2020February 19, 2020

Oral Brilacidin Found to be Well-tolerated in Healthy Volunteers With Delivery Localized to the Colon, Trial Shows

News

Delayed-release oral tablets of brilacidin for ulcerative colitis (UC) was found delivered and dispersed into the colon, and was well-tolerated in healthy volunteers in a Phase 1 trial, announced the ... Read more

June 19, 2019June 19, 2019

Innovation Pharmaceuticals Signs Deal to Use Tablet Technology for Oral Brilacidin Treatment

News

Innovation Pharmaceuticals has signed an agreement to use OralogiK — an advanced tablet-coating technology patented by BDD Pharma — to develop tablets for targeted oral delivery of Brilacidin for treating ... Read more